Better For You Wellness (BFYW) 10-Q 16 Oct 23 2023 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Aug. 31, 2023	Oct. 16, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Aug. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Registrant Name	Better For You Wellness, Inc.
Entity Central Index Key	0001852707
Entity File Number	000-56262
Entity Tax Identification Number	87-2903933
Entity Incorporation, State or Country Code	NV
Current Fiscal Year End Date	--02-28
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, Address Line One	1349 East Broad Street
Entity Address, City or Town	Columbus
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43205
City Area Code	(614)
Local Phone Number	368-9898
Entity Common Stock, Shares Outstanding		419,209,183

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Current assets:
Cash and cash equivalents	$ 3,209	$ 13,773
Accounts receivable	2,259	1,460
Prepaid expenses	10,020	18,493
Other receivable	29,324	0
Inventory	910	979
Total current assets	45,722	34,705
Equipment, net	1,159	1,547
Goodwill	583,484	583,484
Right-of-use assets - operating leases	196,034	0
Total assets	826,399	619,736
Current liabilities:
Accounts payable and accrued expenses	614,840	391,553
Deferred compensation	248,976	379,759
Notes payable- related party	$ 291,500	$ 293,000
Notes Payable, Current, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Accrued interest	$ 104,348	$ 60,243
Operating lease liabilities - current portion	73,608	0
Convertible notes payable, net of discount	620,000	594,804
Notes payable - paypal capital	1,876	2,103
Notes payable- shopify capital	103	121
Total current liabilities	1,955,251	1,721,583
Long-term liabilities
Lease liability- net of current portion	122,426	0
Total long-term liabilities	122,426	0
Total liabilities	2,077,677	1,721,583
Commitments and contingencies (Note 14)
STOCKHOLDERS' DEFICIT:
Preferred stock ($0.0001 par value, 200,000,000 shares authorized; 700,000 shares issued and outstanding as of August 31, 2023 and February 28, 2023)	70	70
Common stock ($0.0001 par value, 500,000,000 shares authorized, 419,209,183 and 404,014,987 issued and outstanding as of August 31, 2023 and February 28, 2023, respectively)	41,923	40,403
Additional paid in capital	6,016,408	4,933,281
Accumulated deficit	(7,309,679)	(6,075,601)
Total stockholders' deficit	(1,251,278)	(1,101,847)
TOTAL LIABILITIES & EQUITY (DEFICIT)	$ 826,399	$ 619,736

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Aug. 31, 2023	Feb. 28, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	700,000	700,000
Preferred stock, shares outstanding	700,000	700,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	419,209,183	404,014,987
Common stock, shares outstanding	419,209,183	404,014,987

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Revenue
Merchandise sales	$ 1,804	$ 1,716	$ 3,654	$ 2,022
Cost of goods sold	(381)	(3,489)	(1,313)	(9,558)
Gross profit (loss)	1,423	(1,773)	2,341	(7,536)
Operating expenses
Share based expenses	180,718	227,619	573,668	995,932
Selling, general and administrative	281,394	446,262	593,450	643,257
Total operating expenses	462,112	673,881	1,167,118	1,639,189
Operating loss	(460,689)	(675,654)	(1,164,777)	(1,646,725)
Other expense
Interest expense	(25,505)	(17,980)	(69,301)	(23,043)
Total other expense	(25,505)	(17,980)	(69,301)	(23,043)
Net loss	$ (486,194)	$ (693,634)	$ (1,234,078)	$ (1,669,768)
Net loss per common shares outstanding – basic	$ 0	$ 0	$ 0	$ 0
Net loss per common shares outstanding – diluted	$ 0	$ 0	$ 0	$ 0
Weighted average common shares outstanding – basic	411,804,068	372,031,446	407,943,223	372,031,446
Weighted average common shares outstanding – diluted	411,804,068	372,031,446	407,943,223	372,031,446

Consolidated and Condensed Stat

Consolidated and Condensed Statements of Changes in Stockholder's (Deficit) - USD ($)	Total	Common Shares	Additional Paid-in Capital	Shares Cancelable	Accumulated Deficit	Class A Preferred Shares Preferred Shares
Balance at Feb. 28, 2022	$ (365,766)	$ 37,075	$ 2,395,265	$ (250,000)	$ (2,548,176)	$ 70
Balance (in Shares) at Feb. 28, 2022		370,747,042				700,000
Common shares issued for shares payable	0	$ 33	(33)
Common shares issued for shares payable (in Shares)		325,000
Common shares issued for cash received	3,750	$ 3	3,747
Common shares issued for cash received (in Shares)		30,282
Common shares cancelled and returned to the company (in Shares)		(7,048,873)
Common shares cancelled and returned to the company		$ (705)	(249,295)	250,000
Common shares issued for services to the company	523,433	$ 1,015	522,418
Common shares issued for services to the company (in Shares)		10,145,000
Common shares issued for purchase of Mango Moi	550,000	$ 1,100	548,900
Common shares issued for purchase of Mango Moi (in Shares)		11,000,000
Stock option expense	917,062		917,062
Warrants issued	30,702		30,702
Debt forgiveness	49,686		49,686
Net loss	(1,669,768)				(1,669,768)
Forfeiture of stock compensation	(444,563)		(444,563)
Balance at Aug. 31, 2022	(405,464)	$ 38,521	3,773,889	0	(4,217,944)	$ 70
Balance (in Shares) at Aug. 31, 2022		385,198,451				700,000
Balance at May. 31, 2022	39,613	$ 38,012	3,525,841	0	(3,524,310)	$ 70
Balance (in Shares) at May. 31, 2022		380,108,169				700,000
Common shares issued for cash received	3,750	$ 3	3,747
Common shares issued for cash received (in Shares)		30,282
Common shares issued for services to the company	250,698	$ 506	250,192
Common shares issued for services to the company (in Shares)		5,060,000
Stock option expense	421,484		421,484
Warrants issued	17,188		17,188
Net loss	(693,634)				(693,634)
Forfeiture of stock compensation	(444,563)		(444,563)
Balance at Aug. 31, 2022	(405,464)	$ 38,521	3,773,889	0	(4,217,944)	$ 70
Balance (in Shares) at Aug. 31, 2022		385,198,451				700,000
Balance at Feb. 28, 2023	(1,101,847)	$ 40,403	4,933,281	0	(6,075,601)	$ 70
Balance (in Shares) at Feb. 28, 2023		404,014,987				700,000
Common shares issued for services to the company	11,950	$ 98	11,852
Common shares issued for services to the company (in Shares)		975,194
Stock option expense	546,594		546,594
Common shares issued for settlement of debt	195,000	$ 527	194,473
Common shares issued for settlement of debt (in Shares)		5,270,271
Common shares issued for settlement of deferred compensation	331,103	$ 895	330,208
Common shares issued for settlement of deferred compensation (in Shares)		8,948,731
Net loss	(1,234,078)				(1,234,078)
Balance at Aug. 31, 2023	(1,251,278)	$ 41,923	6,016,408	0	(7,309,679)	$ 70
Balance (in Shares) at Aug. 31, 2023		419,209,183				700,000
Balance at May. 31, 2023	(1,464,343)	$ 40,413	5,318,659	0	(6,823,485)	$ 70
Balance (in Shares) at May. 31, 2023		404,114,987				700,000
Common shares issued for services to the company	11,000	$ 88	10,912	0
Common shares issued for services to the company (in Shares)		875,194
Stock option expense	162,156		162,156
Common shares issued for settlement of debt	195,000	$ 527	194,473
Common shares issued for settlement of debt (in Shares)		5,270,271
Common shares issued for settlement of deferred compensation	331,103	$ 895	330,208
Common shares issued for settlement of deferred compensation (in Shares)		8,948,731
Net loss	(486,194)				(486,194)
Balance at Aug. 31, 2023	$ (1,251,278)	$ 41,923	$ 6,016,408	$ 0	$ (7,309,679)	$ 70
Balance (in Shares) at Aug. 31, 2023		419,209,183				700,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (1,234,078)	$ (1,669,768)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation expense	558,544	995,932
Amortization of debt discount & issuance costs	25,196	49,475
Depreciation	388	388
Changes in Operating Assets and Liabilities:
Accounts receivable	(799)	(123)
Inventory	69	7,899
Related Party Receivable	0	(107,068)
Prepaid expenses	8,473	0
Other receivable	(29,324)	0
Accounts payable	223,287	(117,587)
Accrued interest	44,105	23,043
Deferred compensation	200,320	190,320
Other current liabilities	(245)	(1,409)
Net Cash Used in Operating Activities	(204,064)	(628,898)
Cash Flows from Investing Activities:
Acquisition of businesses, net of cash acquired	0	(6,087)
Purchases of property and equipment	0	(2,323)
Net Cash Used in Investing Activities	0	(8,410)
Cash Flows from Financing Activities:
Payment of debt issuance cost	0	(56,640)
Proceeds from convertible loan, net of original issue discount	0	558,000
Proceeds received from Notes payable- related party	211,000	75,000
Repayment of Notes payable- related party	(17,500)	0
Common stock issuance	0	3,750
Expenses contributed to capital	0	49,686
Net Cash Flows from Financing Activities	193,500	629,796
Net decrease in cash	(10,564)	(7,512)
Cash at beginning of the year:	13,773	9,642
Cash at end of the year:	3,209	2,130
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Common stock issued for acquisition	0	550,000
Common stock issued to settle liability	0	17,500
Discount on Notes Payable for Warrants	0	30,702
Common stock issued for settlement of debt	195,000	0
Common stock issued for settlement of deferred compensation.	$ 331,103	$ 0

Organization and Description of

Organization and Description of Business	6 Months Ended
	Aug. 31, 2023
Accounting Policies [Abstract]
Organization and Description of Business	Note 1 - Organization and Description of Business Better For You Wellness, Inc. (we, us, our, the “Company” or the “Registrant”) was initially incorporated with the name Fast Track Solutions, Inc. in the State of Nevada on December 1, 2020. A plant-based, science-focused wellness consumer packaged goods and sustainable services Company evaluating opportunities targeting six goals-based wellness categories within the rapidly growing wellness industry to create a leading global wellness conglomerate. The Company’s current business plan is to explore and evaluate various opportunities in the plant-based skincare, personal care, food and beverage, natural supplement and consumer packaged goods and services sectors. The Company acquired Mango Moi, a natural skincare company in May 2022 and intends to optimize Mango Moi’s product formulae and packaging, as well as secure new manufacturing relationships to scale production capacity. Additionally, the Company plans to expand Mango Moi’s product offerings to include additional products and product bundles. Furthermore, the Company intends to grow sales through direct-to-consumer marketing efforts, subscription box sales, and pursuing wholesale sales relationships. The Company intends to acquire The Ideation Lab, LLC and its functional beverage division, The Jordre Well. The Ideation Lab is a brand solutions incubator and accelerator focused on the plant-based wellness and hemp-infused industry. The Ideation Lab has been developing plant-based wellness brands since 2020, including Garrett and Emmett’s Pet Treats, a pet lifestyle brand, E.J. Well Co, a women’s wellness brand, and others. The Jordre Well is a functional beverage company that is 49% owned by Coffee Holding Co., Inc. (NASDAQ: JVA), a leading integrated wholesale coffee roaster and dealer in the United States. In September, 2022, The Jordre Well announced its portfolio of products from Stephen James Curated Coffee Collection (“SJCCC”), the Company’s premium coffee brand, which is now being sold through Amazon.com and is in discussion with major national retailers. The e-commerce giant carries 8 of SJCCC’s premium coffee products and ships to more than 100 countries around the globe. Additionally, the deal contemplates Coffee Holding Company continuing its global purchase of coffee beans, manufacturing, distribution, and licensure of its Cafe Caribe and Harmony Bay to The Jordre Well for Hemp infusion. The Company’s current business plan is to explore and evaluate various opportunities in the plant-based food and beverage and consumer packaged goods sectors, including but not limited to, mergers, acquisitions, or business combination transactions. The Company’s principal business objective for the next 12 months and beyond will be to achieve long-term growth potential through a business combination rather than immediate, short-term earnings. On September 18, 2023, the company entered into Membership Interest Purchase Agreement (MIPA) with The Ideation Lab, LLC, an Ohio limited liability company (TIL)(“sellers”). The purchase price as determined is $3M valuation. In connection with MIPA agreement On October 1, 2023, each Seller was given the choice to receive their pro-rata portion of the Consideration Shares in the form of restricted Better For You Wellness, Inc. Series A Preferred Stock $0.0001 par value or restricted Better For You Wellness, Inc. Common Stock par value $0.0001. Each share of BFYW Preferred Stock has voting rights equal to one thousand (1,000) votes of each share of BFYW Common Stock. The Company’s main office is located at 1349 East Broad Street, Columbus OH 43205.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Aug. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Principles of Consolidation The accompanying interim unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). These condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Mango Moi and Glow Markets, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. Significant Accounting Policies and Use of Estimates: There were no material changes in the Company’s significant accounting policies for the six months ended August 31, 2023 as compared to the year ended February 28, 2023 except for lease accounting for operating lease entered into in Q1, where the company has applied Accounting Standards Codification (ASC) 842 (See Note 7). Further, see Note 2 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2023, as filed with the SEC, for additional information regarding the Company’s significant accounting policies and use of estimates. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ significantly from those estimates. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates of stock option valuation, Right-of-use assets - operating leases, lease liability and the valuation allowance associated with the Company’s deferred tax assets. Interim Financial Statements The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of August 31, 2023 and for the related periods presented, have been included. The results for the six-months period ended August 31, 2023 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the year ended February 28, 2023 issued on June 9, 2023. Revenue Recognition The Company has prepared its unaudited condensed consolidated financial statements in accordance with GAAP. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. The Company adopted ASC 606 - Revenue from contracts with Customers: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. Revenue for products is recognized when the products are delivered to the customer, and the customer completes the product inspection. Cash receipts for undelivered products are recorded as deferred revenues. As of August 31, 2023 and 2022, the Company had no deferred revenues. Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s unaudited condensed consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at August 31, 2023 and February 28, 2023 were $3,209 and $ 13,773 respectively. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method over the estimated useful lives of the related assets (primarily three Inventory Inventories, which include the costs of material, labor and overhead, are stated at the lower of cost or net realizable value, with cost computed on a first-in, first-out basis. Better Suds manufactures only what it sells in a drop ship business model, therefore the Company had $910 and $979 in inventory as of August 31, 2023 and February 28, 2023 respectively. Income Taxes The Company accounts for income taxes under ASC 740, “ Income Taxes a 100% valuation allowance has been established on deferred tax assets at August 31, 2023 and February 28, 2023, due to the uncertainty of our ability to realize future taxable income.” Basic/ Diluted Earnings (Loss) Per Share The Company computes basic and diluted earnings (loss) per share in accordance with ASC Topic 260, Earnings per Share The Company does not have any potentially dilutive instruments as of August 31, 2023 and, thus, anti-dilution issues are not applicable. Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures - Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. - Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. - Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of August 31, 2023. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, prepaid expenses, other receivable, inventory, accounts payable, deferred compensation, notes payable-related party, lease liability current portion and convertible notes. Related Parties The Company follows ASC 850, Related Party Disclosures, Leases: We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases do not provide an implicit rate, the Company elected the practical expedient to utilize the risk-free rate to determine the present value of lease payments. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term. On April 1, 2023, the Company entered into office Lease Agreement, for 9,247 The lease includes the following physical space: 9,247 1,000 10,247 Share-Based Compensation ASC 718, “ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” Except as specified for the Independent Directors’ compensation, the Company had no Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13 “Credit Losses - Measurement of Credit Losses on Financial Instruments.” ASU No. 2016-13 significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables, by replacing today’s “incurred loss” approach with an “expected loss” model under which allowances will be recognized based on expected rather than incurred losses. ASU No. 2016-13 is effective for us in the first quarter of fiscal year 2024. The adoption of ASU No. 2016-13 resulted in no change in the allowance for doubtful accounts.

Going Concern

Going Concern	6 Months Ended
	Aug. 31, 2023
Going Concern [Abstract]
Going Concern	Note 3 - Going Concern The Company’s financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company demonstrates adverse conditions that raise substantial doubt about the Company’s ability to continue as a going concern for one year following the issuance of these financial statements. These adverse conditions are negative financial trends, specifically operating loss, working capital deficiency, and other adverse key financial ratios. The Company has not established any source of revenue to cover its operating costs. Management plans to fund operating expenses with related party contributions to capital. There is no assurance that management’s plan will be successful. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that the Company cannot continue as a going concern.

Convertible Note Payable

Convertible Note Payable	6 Months Ended
	Aug. 31, 2023
Debt Disclosure [Abstract]
Convertible Note Payable	Note 4 - Convertible Note Payable (A) On April 12, 2022, the Company entered into a Securities Purchase Agreement with Mast Hill Fund, L.P., in which Mast Hill purchased a promissory note, with a principal amount of $ 310,000 279,000 31,000 0.037 (B) On June 7, 2022, the Company entered into a second Securities Purchase Agreement with Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”). The first Security Purchase Agreement with Mast Hill Fund, L.P. was entered On April 12, 2022. Pursuant to the June 7, 2022 Security Purchase Agreement, Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the “Note”). The closing of the Purchase Agreements occurred on June 7, 2022. The Note bears an original issue discount of $31,000, each bear interest of 12% per year and mature on June 7, 2023 (the “Maturity Date”). In current quarter the note was in default and default interest rate of 16% was applied from original date of maturity June 7, 2023 to August 31, 2023. The Note is convertible into shares of the Company’s common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements. (C) Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing. In connection with the Purchase Agreements, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Mast Hill, pursuant to which the Company is obligated to file a registration statement within 90 days of the date of the Registration Rights Agreement covering the sale of the Commitment Shares and the shares of the Company’s common stock that may be issued to Mast Hill pursuant to the conversion of the Note. On July 11, 2022, Mast Hill Fund agreed to extend the timeframes in section 2(a) of the Registration Rights Agreement dated April 12,2022 to 180 calendar days to file the initial Registration Statement and 270 calendar days to have it declared effective. On October 11, 2022, Mast Hill Fund agreed to extend the timeframes in section 2(a) of the Registration Rights Agreement dated April 12,2022 until February 9, 2023, and to have the Registration Statement become effective on or before February 9, 2037. Subsequently, i As of August 31, 2023, and February 28, 2023 the balances were $620,000 and $594,804, with accrued interest of $104,348 and $60,243 respectively.

Accounts Receivable

Accounts Receivable	6 Months Ended
	Aug. 31, 2023
Receivables [Abstract]
Accounts Receivable	Note 5 - Accounts Receivable The following table summarizes the Company’s accounts receivable. (Unaudited) For the Six Months Ended August 31, 2023 For the Year Ended February 28, 2023 Accounts Receivable, Gross $ 2,259 $ 1,460 Less: Allowance for Credit Losses — — Accounts Receivable, Net $ 2,259 $ 1,460

Property and Equipment, net

Property and Equipment, net	6 Months Ended
	Aug. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment, net	Note 6 - Property and Equipment, net The Company’s property and equipment for the six months period ended August 31, 2023 and year ended February 28, 2023 are as follows: (Unaudited) For the Six Months Ended August 31, 2023 For the Year Ended February 28, 2023 Equipment $ 1,547 $ 2,323 Less: Accumulated Depreciation (388 ) (776 ) Equipment, net $ 1,159 $ 1,547 The Company recorded depreciation expense of $388 and $388 in the six months ended August 31, 2023 and 2022, respectively.

Operating Lease Right of Use As

Operating Lease Right of Use Asset and Lease Liability	6 Months Ended
	Aug. 31, 2023
Leases [Abstract]
Operating Lease Right of Use Asset and Lease Liability	Note 7 – Operating Lease Right of Use Asset and Lease Liability On April 1, 2023 Company entered into the lease agreement to lease 9,247 square feet office in Columbus, OH. The lease commenced on April 1, 2023, for the next three years starting from April 1, 2023 to March 31, 2026, with two one-year options to extend. The monthly rental payment is $6,650 has been accrued for June, July and August 2023. ROU asset obtained in exchange for new operating lease liability amounting $225,887. The company uses the implicit rate when it is readily determinable. If the Company’s lease does not provide an implicit rate, the Company elected the practical expedient to utilize the risk-free rate to determine the present value of lease payments. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The lease does not provide an implicit rate. Therefore, we have adopted a treasury rate of 3.81%. The lease includes the following physical space: 9,247 square feet (SF) on the first, second, and third floors, the 3,000 SF of storage and fulfillment in the sublevel finished basement, and nearly 1,000 SF of lab space in the first floor of the Carriage House (a cumulative total of approximately 10,247 SF), and secure off-street parking. Operating lease right of use (ROU) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Future lease payments are as follows: For the twelve months ending August 31 Operating Lease 2024 79,800 2025 79,800 2026 46,550 Thereafter — Total lease payments 206,150 Less: present value discount (10,116 ) Total lease liabilities 196,034 Less: current portion (73,608 ) Non-current lease liabilities 122,426 The following table set forth additional information pertaining to our leases: For the six months ending August 31, 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases 6,650 Weighted average remaining lease term – operating leases 2.6 years Weighted average discount rate – operating leases 3.81 %

Note Payable Related Party

Note Payable Related Party	6 Months Ended
	Aug. 31, 2023
Note Payable Related Party [Abstract]
Notes Payable - Related Party	Note 8- Notes Payable - Related Party As of August 31, 2023 and February 28, 2023 the balance of N otes payable related part During the six months period ended August 31, 2023, Company received $171,000 from GOV wholly owned subsidiary of Ian James, $50,000 from our Audit Chairman David Deming. The original loan of $35,000 that was obtained from Mango Moi, LLC and had a remaining balanc 10,000 18 , at 0.037 195,000 related During the year ended February 28, 2023, Company received $32,500 from Mr. James, $48,000 from GOV wholly owned subsidiary of Ian James and $195,000 from our Audit Chairman, David Deming. These are non-interest bearing and unsecured and payable on demand. In addition, the Company acquired $35,000 on October 12, 2022 a loan payable by Mango Moi, LLC to a related party of the seller, Amanda Cayemitte. The Board of Directors authorized the issuance of 760,870 Common Shares at

Deferred Compensation

Deferred Compensation	6 Months Ended
	Aug. 31, 2023
Compensation Related Costs [Abstract]
Deferred Compensation	Note 9 – Deferred Compensation The Company has recognized $248,976 and $379,759 in deferred compensation as of August 31, 2023 and February 28, 2023 respectively and are related to the Employment Agreements for Chief Executive Officer, Chief Branding Officer and Chief Business Development Officer. On July 18, 2023, the accrued deferred compensation of Ian James and Stephen Letourneau amounting $186,096 and $145,007 respectively were settled with issuance of 5,029,622 and 3,919,109 shares of Company’s common stock at an agreed upon price of $0.037 per share pursuant to an authorization from the Board of Directors.

Stock Purchase Warrant Liabilit

Stock Purchase Warrant Liability	6 Months Ended
	Aug. 31, 2023
Stock Purchase Warrant Liability [Abstract]
Stock Purchase Warrant Liability	Note 10 - Stock Purchase Warrant Liability On April 18, 2022, we entered into a Standby Equity Commitment Agreement with MacRab LLC, a Florida limited liability company providing us with an option to sell up to $5,000,000 worth of our Common Stock, par value $0.0001, to MacRab LLC, in increments, over the period ending 24 months after the date that the Company’s registration statement is deemed effective by the U.S. Securities and Exchange Commission, pursuant to the terms and conditions contained in the SECA. Additionally, we issued MacRab LLC a Common Stock purchase warrant for the purchase of 1,785,714 shares of our common stock as a commitment fee in connection with the execution of the Standby Equity Commitment Agreement. We also entered into a Registration Rights Agreement with the Investor requiring the Company to file a registration statement providing for the registration of the Common Stock issuable to MacRab LLC under the Standby Equity Commitment Agreement and their common stock purchase warrant, and the subsequent resale by MacRab LLC of such Common Stock. JH Darbie & Co., Inc. (“JH Darbie”) and the Company are parties to a Finder’s Fee Agreement, signed March 15, 2020 (“Finder’s Agreement”) pursuant to which JH Darbie would introduce the Issuer to third-party investors. Pursuant to the Finder’s Agreement, in relation to the April 12, 2022 and the June 7, 2022 Securities Purchase Agreement with Mast Hill Fund, L.P., two equal payments of fees of approximately $22,320 were paid to JH Darbie. In addition, JH Darbie is to receive non-callable warrants of equal to 8% warrant coverage of the amount raised. The warrants shall entitle JH Darbie thereof to purchase common stock of the Company at a purchase price equal to 120% of the exercise price of the transaction or the public market closing price of the Issuer’s common stock on the date of the Transaction, whichever is lower (such price, the “Warrant Price”). The warrants shall be exercisable immediately after the date of issuance, shall have anti-dilutive price protection, participating registration rights, and shall expire 5 years after the date of issuance, in accordance with the Finder’s Agreement.

Shareholder Equity

Shareholder Equity	6 Months Ended
	Aug. 31, 2023
Stockholders' Equity Note [Abstract]
Shareholder Equity	Note 11 - Shareholder Equity Preferred Stock The authorized preferred stock of the Company consists of 200,000,000 shares with a par value of $0.0001. There were 700,000 and 700,000 shares issued and outstanding as of August 31, 2023 and February 28, 2023, respectively. Common Stock The authorized common stock of the Company consists of 500,000,000 shares with a par value of $0.0001. There were 419,209,183 and 404,014,987 shares of common stock issued and outstanding as of August 31, 2023 and February 28, 2023, respectively. Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 commitment shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing. On April 12, 2022, 125,000 shares of Restricted Common Stock were issued to five Directors serving on the Company’s Board of Directors as compensation for services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totaled approximately $15,468. On May 26, 2022, 11,000,000 shares of Restricted Common Stock were issued to the two Sellers of Mango Moi, LLC (See Note 1). The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totaled approximately $550,000. During the period ended May 31, 2022, a total of 325,000 shares of Restricted Common Stock were sold to two shareholders for proceeds totaling approximately $40,248. On March 31, 2023, 100,000 shares of Restricted Common Stock were issued to four Directors serving on the Company’s Board of Directors as compensation for services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totaled approximately $950. On June 30, 2023, 100,000 shares of Restricted Common Stock were issued to four Directors serving on the Company’s Board of Directors as compensation for services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totaled approximately $1,000. On June 30, 2023, 775,194 shares of Restricted Common Stock were issued to the Company’s Fractional CFO as compensation for services to the company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totaled approximately $10,000. On July 18, 2023, the accrued deferred compensation of Ian James and Stephen Letourneau amounting $186,096 and $145,007, respectively were settled with issuance of 5,029,622 and 3,919,109 shares of the company’s common stock at an agreed upon price of $0.037 per share pursuant to an authorization from the Boad of Directors. On July 18, 2023, the loan of David Deming amounting $195,000 was settled with issuance of 5,270,271 shares of company’s common stock at an agreed upon price of $0.037 per share pursuant to an authorization from Board of Directors. Shares Cancelable On July 11, 2022, the Company entered into a Common Share Option Cancellation and Forfeiture Agreement with former Director Dr. Nicola Finley (the “Option Cancellation and Forfeiture Agreement”). Under the Option Cancellation and Forfeiture Agreement, Dr. Nicola Finley forfeited, and the Company canceled Dr. Nicola Finley’s option to purchase 4,000,000 common shares of the Company that was granted to the optionee pursuant to the Director Agreement dated as of August 29, 2021. Upon such forfeiture and cancellation, Dr. Nicola Finley has no further rights to exercise the option to purchase 4,000,000 common shares of the Company. The cancellation and forfeiture set forth in the Option Cancellation and Forfeiture Agreement shall not affect the restricted common shares granted by the Company to Dr. Nicola Finley pursuant to the Director Agreement dated as of August 29, 2021. As a payment in lieu of whatever benefits, if any, to which Dr. Nicola Finley may have been entitled to under the option to purchase 4,000,000 common shares of the Company, the Company shall pay Dr. Nicola Finley $1.00. No shares were cancelled during three or six months Stock Options During the year ended February 28, 2023, the Company granted options exercisable for up to 20,000,000 shares of Common Stock of which 14,000,000 fully vested on February 28, 2023. The remaining 6,000,000 shares vest over the next year. The Company fair valued the options on the grant date at $4,853,749 using a Black-Scholes option pricing model. The following assumptions: stock price of $.22 per share (based on the quoted trading price on the date of grant 9/30/2021), volatility of 172%, expected term of 5 years, and a risk-free interest rate range of 1.01% for options with grant date September 30,2021 and assumptions for option granted on January 1,2022: stock price of $.11 per share (based on the quoted trading price on the date of grant 1/1/2022) , volatility of 163%, expected term of 5 years, and a risk-free interest rate range of 1.26%. The Company is amortizing the expense using straight line method over the vesting terms of each. The total stock option expense for the six months period ended August 31, 2023 and 2022 were $546,594 and $917,062 respectively. Stock option granted to Director Leslie Bumgarner totaled $703,891 expired due to resignation effective December 31, 2021 and stock option granted totaled $444,563 to Dr. Nicola Finley was forfeited on her resignation dated June 18, 2022. The total unamortized stock option expense as of August 31, 2023 and February 28, 2023 were

Goodwill

Goodwill	6 Months Ended
	Aug. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 12 - Goodwill While changes in circumstances requiring a goodwill impairment test have not been identified for the period ended August 31, 2023. The Company will continue to monitor circumstances, such as disposition activity, stock price declines or changes in forecasted cash flows in future periods. If the fair value of the Company’s reporting unit declines below the carrying value in the future, goodwill impairment charges may be incurred.

Business Combination

Business Combination	6 Months Ended
	Aug. 31, 2023
Business Combinations [Abstract]
Business Combination	Note 13 – Business Combination On April 29, 2022, we entered into an asset purchase agreement to acquire substantially all of the assets of Mango Moi. The acquisition was accounted for in accordance with GAAP and was made to expand our market share in the personal care category and due to synergies of product lines and services between the Companies. The acquisition closed May 26, 2022. Mango Moi is a hair and skincare business located in Chicago, Illinois. Pursuant to the MIPA, in exchange for the MM Interests, the Company agreed to pay the Sellers a purchase price consisting of shares of the Company’s common stock, par value $0.0001 per share which consists of 11,000,000 shares of common stock (the “Company Common Stock”), with a fair market value of approximately $550,000, with 5,720,000 shares of Company Common Stock issued to Amanda Cayemitte and 5,280,000 shares of Company Common Stock issued to Yapo M’be (referred to together herein as the “Purchase Price”). The purchase price has been preliminarily allocated to assets acquired and liabilities assumed based on the estimated fair value of such assets and liabilities at the date of acquisitions as follows: Assets Acquired: Cash $ 913 Inventory 12,995 Total Assets Acquired 13,908 Liabilities assumed: Clearbanc debit card 2,365 Notes payable - paypal capital 2,454 Notes payable shopify capital 537 Sales tax payable 36 Note payable gushy 35,000 Total liabilities assumed 40,392 Total identifiable net assets (26,484 ) Purchase price 557,000 Goodwill - excess of purchase price over fair value of net assets acquired on acquisition date $ 583,484 The purchase price of $557,000 was paid in stock and discharge of liability. Goodwill in the amount of $583,484 was recognized in the acquisition of Mango Moi LLC and is attributable to the cash flows of the business derived from our potential to outperform the market due to its existing relationship and other synergies created within the Company.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Aug. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 14 - Commitments and Contingencies Employment Agreements On July 21, 2022 the Company’s Compensation Committee approved a formal Employment Agreement with Ian James, the Company’s Chief Executive Officer, Stephen Letourneau, the Company’s Chief Branding Officer and Jacob Ellman, the Company’s Chief Business Development Officer. Beginning March 1, 2022, as compensation under the Employment Agreement, Ian James will earn a Base Salary in the amount of $199,196 per annum, $16,599.67 per month, and be eligible to earn an additional payment (BONUS) of $68,328, Stephen Letourneau will earn a Base Salary in the amount of $152,787 per annum, $12,732.25 per month, and be eligible to earn an additional payment (BONUS) of $41,140, and Jacob Ellman will earn a Base Salary in the amount of $128,656 per annum, $10,721.33 per month, and be eligible to earn an additional payment (Bonus) of $70,632. Each Employee salary less statutory and other required deductions, for all work and services the Employee respectively performs for the Company. The Company calculates Annual Base Salary on a January 1 through December 31 basis (i.e., a calendar year). Base Salary payments shall be subject to applicable federal, state, and local withholding. Under the Agreement, the Employee and Company mutually agree that until the Company is cash flow positive, the Company shall pay Employee a mutually agreeable amount each month toward the Employee’s Base Salary, and the balance of Base Salary unpaid, shall be accrued and recorded as an obligation of the Company. It shall become payable to the Employee when the Company is cash flow positive or at a time mutually agreed by the Company and Employee. The Employees and Company consider the Bonus Pay as “at-risk” and therefore not guaranteed. Bonus Pay could include a cash bonus, commission, and other at-risk pay categories. Bonus shall be determined at the sole discretion of the Company. The Employee’s Bonus shall be based on Employee’s annual performance reviews and overall company performance, subject to the terms and conditions of applicable incentive plans and policies. Should the Employee’s Contract be terminated, payments under Section 2 shall cease; provided, however, that Employee shall be entitled to Base Salary and accrued Base Salary for periods or partial periods that occurred before the date of termination and for which the Employee has not yet been paid and for any commission earned per the Company’s customary procedures, if applicable. After completion of 90 15 Employee shall be permitted to carry over into the following year of employment a maximum of five days of Personal Leave; however, as of December 31, Employee shall forfeit unused Personal Leave benefits above five days. Further, Employee shall not be permitted to carry over or accumulate more than five days of Personal Leave from one year to the next. Lease Agreements Refer Note 7 for operating lease details.

Subsequent Events

Subsequent Events	6 Months Ended
	Aug. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 15 - Subsequent Events On September 18, 2023, the company entered into the amendment of promissory note of Mast Hill Fund L.P. dated April 12, 2022, in original amount of $310,000. With the amendment effects, the outstanding principal balance of the note will be increased by $40,891, the interest rate will increase to 18%, and the maturity date has been extended to September 13, 2024. On September 18, 2023, the company entered into the amendment of promissory note of Mast Hill Fund L.P. dated 7, 2022, in original amount of $310,000. With the amendment effects, the outstanding principal balance of the note will be increased by $40,023, the interest rate will increase to 18%, and the maturity date has been extended to September 13, 2024. On September 18, 2023, the company entered into Membership Interest Purchase Agreement (MIPA) with The Ideation Lab, LLC, an Ohio limited liability company (TIL)(“sellers”). The purchase price as determined , E until October 1, 2023 to elect to receive their pro-rata portion of the Consideration Shares in the form of restricted Better For You Wellness, Inc. Series A Preferred Stock By October 1, 2023, the election resulted in The Ideation Lab shareholders unanimously electing to be issued Series A Preferred Stock at the close of the transaction. On September 26, 2023, Montel Williams and David H. Deming were each re-appointed by our Board of Directors to serve as Independent Directors of the Company. Likewise, on October 1, 2023, Joseph James Watson was reappointed to the Board of Directors. Each director will serve two-year terms, with the option to renew terms upon completion and receive cash compensation in the amount of $1,000 per quarter, paid in equal distributions quarterly, 200,000 shares of common stock issued quarterly in 25,000 share distributions. The Board evaluated Montel Williams,’ David H. Deming’s and Joseph Watson’s independence per the independence standards for directors outlined in Rule 5602(a)(2) of the Nasdaq Listing Rules and affirmatively determined that both qualifies as an independent director. On October 11, 2023, The Ideation Lab shareholder election results reflected that all The Ideation Lab shareholders would be issued BFYW Series A Preferred Stock at the close of the transaction.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Aug. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying interim unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). These condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Mango Moi and Glow Markets, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation.
Significant Accounting Policies and Use of Estimates	Significant Accounting Policies and Use of Estimates: There were no material changes in the Company’s significant accounting policies for the six months ended August 31, 2023 as compared to the year ended February 28, 2023 except for lease accounting for operating lease entered into in Q1, where the company has applied Accounting Standards Codification (ASC) 842 (See Note 7). Further, see Note 2 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2023, as filed with the SEC, for additional information regarding the Company’s significant accounting policies and use of estimates. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ significantly from those estimates. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates of stock option valuation, Right-of-use assets - operating leases, lease liability and the valuation allowance associated with the Company’s deferred tax assets.
Interim Financial Statements	Interim Financial Statements The accompanying unaudited interim condensed financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in shareholders’ deficit and cash flows as of August 31, 2023 and for the related periods presented, have been included. The results for the six-months period ended August 31, 2023 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto for the year ended February 28, 2023 issued on June 9, 2023.
Revenue Recognition	Revenue Recognition The Company has prepared its unaudited condensed consolidated financial statements in accordance with GAAP. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. The Company adopted ASC 606 - Revenue from contracts with Customers: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. Revenue for products is recognized when the products are delivered to the customer, and the customer completes the product inspection. Cash receipts for undelivered products are recorded as deferred revenues. As of August 31, 2023 and 2022, the Company had no deferred revenues.
Basis of Presentation	Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s unaudited condensed consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements.
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at August 31, 2023 and February 28, 2023 were $3,209 and $ 13,773 respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method over the estimated useful lives of the related assets (primarily three
Inventory	Inventory Inventories, which include the costs of material, labor and overhead, are stated at the lower of cost or net realizable value, with cost computed on a first-in, first-out basis. Better Suds manufactures only what it sells in a drop ship business model, therefore the Company had $910 and $979 in inventory as of August 31, 2023 and February 28, 2023 respectively.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “ Income Taxes a 100% valuation allowance has been established on deferred tax assets at August 31, 2023 and February 28, 2023, due to the uncertainty of our ability to realize future taxable income.”
Basic/ Diluted Earnings (Loss) Per Share	Basic/ Diluted Earnings (Loss) Per Share The Company computes basic and diluted earnings (loss) per share in accordance with ASC Topic 260, Earnings per Share The Company does not have any potentially dilutive instruments as of August 31, 2023 and, thus, anti-dilution issues are not applicable.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures - Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. - Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. - Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of August 31, 2023. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, prepaid expenses, other receivable, inventory, accounts payable, deferred compensation, notes payable-related party, lease liability current portion and convertible notes.
Related Parties	Related Parties The Company follows ASC 850, Related Party Disclosures,
Leases	Leases: We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) as assets, operating lease non-current liabilities, and operating lease current liabilities in our balance sheet. ROU assets represent the right to use an asset for the lease term and lease liability represent the obligation to make lease payment arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over lease term. As most of the leases do not provide an implicit rate, the Company elected the practical expedient to utilize the risk-free rate to determine the present value of lease payments. The operating ROU asset also includes any lease payments made and exclude lease incentives. Lease expense for lease payment is recognized on a straight-line basis over lease term. On April 1, 2023, the Company entered into office Lease Agreement, for 9,247 The lease includes the following physical space: 9,247 1,000 10,247
Share-Based Compensation	Share-Based Compensation ASC 718, “ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” Except as specified for the Independent Directors’ compensation, the Company had no
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13 “Credit Losses - Measurement of Credit Losses on Financial Instruments.” ASU No. 2016-13 significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables, by replacing today’s “incurred loss” approach with an “expected loss” model under which allowances will be recognized based on expected rather than incurred losses. ASU No. 2016-13 is effective for us in the first quarter of fiscal year 2024. The adoption of ASU No. 2016-13 resulted in no change in the allowance for doubtful accounts.

Accounts Receivable (Tables)

Accounts Receivable (Tables)	6 Months Ended
	Aug. 31, 2023
Receivables [Abstract]
Schedule of Accounts Receivable	(Unaudited) For the Six Months Ended August 31, 2023 For the Year Ended February 28, 2023 Accounts Receivable, Gross $ 2,259 $ 1,460 Less: Allowance for Credit Losses — — Accounts Receivable, Net $ 2,259 $ 1,460

Property and Equipment, net (Ta

Property and Equipment, net (Tables)	6 Months Ended
	Aug. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	The Company’s property and equipment for the six months period ended August 31, 2023 and year ended February 28, 2023 are as follows: (Unaudited) For the Six Months Ended August 31, 2023 For the Year Ended February 28, 2023 Equipment $ 1,547 $ 2,323 Less: Accumulated Depreciation (388 ) (776 ) Equipment, net $ 1,159 $ 1,547

Operating Lease Right of Use _2

Operating Lease Right of Use Asset and Lease Liability (Tables)	6 Months Ended
	Aug. 31, 2023
Leases [Abstract]
Schedule of lease payments	Future lease payments are as follows: For the twelve months ending August 31 Operating Lease 2024 79,800 2025 79,800 2026 46,550 Thereafter — Total lease payments 206,150 Less: present value discount (10,116 ) Total lease liabilities 196,034 Less: current portion (73,608 ) Non-current lease liabilities 122,426
Schedule of additional information pertaining to our leases	The following table set forth additional information pertaining to our leases: For the six months ending August 31, 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases 6,650 Weighted average remaining lease term – operating leases 2.6 years Weighted average discount rate – operating leases 3.81 %

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Aug. 31, 2023
Business Combinations [Abstract]
Schedule of fair value of such assets and liabilities	The purchase price has been preliminarily allocated to assets acquired and liabilities assumed based on the estimated fair value of such assets and liabilities at the date of acquisitions as follows: Assets Acquired: Cash $ 913 Inventory 12,995 Total Assets Acquired 13,908 Liabilities assumed: Clearbanc debit card 2,365 Notes payable - paypal capital 2,454 Notes payable shopify capital 537 Sales tax payable 36 Note payable gushy 35,000 Total liabilities assumed 40,392 Total identifiable net assets (26,484 ) Purchase price 557,000 Goodwill - excess of purchase price over fair value of net assets acquired on acquisition date $ 583,484

Organization and Description _2

Organization and Description of Business (Details) $ / shares in Units, $ in Millions	1 Months Ended
	Sep. 20, 2022	Sep. 18, 2023 USD ($) Votes $ / shares	Aug. 31, 2023 $ / shares	Feb. 28, 2023 $ / shares
Organization and Description of Business (Details) [Line Items]
Common stock, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Warrant coverage raised percentage	49%
Preferred stock, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Subsequent Event [Member] | Ideation Lab LLC [Member] | Membership Interest Purchase Agreement [Member]
Organization and Description of Business (Details) [Line Items]
Common stock, par value (in Dollars per share)		$ 0.0001
Amount payable for the purchase of membership interest | $		$ 3
Preferred stock, par value (in Dollars per share)		$ 0.0001
Preferred stock number of votes per share | Votes		1,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($)	6 Months Ended	12 Months Ended
	Aug. 31, 2023	Feb. 28, 2023	Apr. 01, 2023
Property, Plant and Equipment [Line Items]
Inventory	$ 910	$ 979
Cash and cash equivalents	13,773	3,209
Contract with customer, liability	0	$ 0
Deferred tax assets, Net	$ 0
Lessee, Operating Lease, Term of Contract			3 years
Treasury Rate			3.81%
Valuation Allowance On Deferred Tax Assets	100%	100%
Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	5 years

Convertible Note Payable - Addi

Convertible Note Payable - Additional Information (Details) - USD ($)				2 Months Ended
	Jul. 11, 2022	Jun. 07, 2022	Apr. 12, 2022	Jun. 07, 2022	Sep. 18, 2023	Sep. 01, 2023	Aug. 31, 2023	Feb. 28, 2023
Disclosure In Entirety Of Convertible Note [Line Items]
Convertible debt current							$ 620,000	$ 594,804
Interest payable							$ 104,348	$ 60,243
Securities Purchase Agreement One [Member] | Promissory Note Amendment Agreement [Member] | Subsequent Event [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Debt instrument face value					$ 310,000
Long-Term Debt, Maturity Date					Sep. 13, 2024
Securities Purchase Agreement Two [Member] | Promissory Note Amendment Agreement [Member] | Subsequent Event [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Debt instrument face value					$ 310,000
Long-Term Debt, Maturity Date					Sep. 13, 2024
Mast Hill Fund LLP [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Threshold time limit for filing the initial registration statement	180 days
Threshold time limit for resgistration to be declared effective	270 days
Mast Hill Fund LLP [Member] | Commitment Shares [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Stock issued during the period shares				4,960,000
Mast Hill Fund LLP [Member] | Securities Purchase Agreement One [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Debt instrument face value			$ 310,000
Proceeds from convertibe debt net			279,000
Debt instrument unamortized discount gross current			$ 31,000
Short term debt fixed interest rate percentage			12%
Debt instrument maturity date			Apr. 12, 2023
Debt instrument conversion price per share			$ 0.037
Number of trading days prior to the prepayment for entitement of conversion of debt into equity			7 days
Mast Hill Fund LLP [Member] | Securities Purchase Agreement One [Member] | Promissory Note Amendment Agreement [Member] | Subsequent Event [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Long-Term Debt, Maturity Date						Sep. 13, 2024
Mast Hill Fund LLP [Member] | Securities Purchase Agreement Two [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Debt instrument face value		$ 310,000		$ 310,000
Proceeds from convertibe debt net		279,000
Debt instrument unamortized discount gross current		$ 31,000		$ 31,000
Short term debt fixed interest rate percentage		12%		12%			16%
Debt instrument maturity date		Jun. 07, 2023
Debt instrument conversion price per share		$ 0.037		$ 0.037
Number of trading days prior to the prepayment for entitement of conversion of debt into equity		7 days
Mast Hill Fund LLP [Member] | Securities Purchase Agreement Two [Member] | Promissory Note Amendment Agreement [Member] | Subsequent Event [Member]
Disclosure In Entirety Of Convertible Note [Line Items]
Long-Term Debt, Maturity Date						Sep. 13, 2024

Accounts Receivable - Schedule

Accounts Receivable - Schedule of Accounts Receivable (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Receivables [Abstract]
Accounts Receivable, Gross	$ 2,259	$ 1,460
Less: Allowance for Credit Losses	0	0
Accounts Receivable, Net	$ 2,259	$ 1,460

Property and Equipment, net - S

Property and Equipment, net - Schedule of Property, Plant and Equipment (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Property, Plant and Equipment [Abstract]
Equipment	$ 1,547	$ 2,323
Less: Accumulated Depreciation	(388)	(776)
Equipment, net	$ 1,159	$ 1,547

Property and Equipment, net (De

Property and Equipment, net (Details) - USD ($)	6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 388	$ 388

Operating Lease Right of Use _3

Operating Lease Right of Use Asset and Lease Liability (Details) - USD ($)		3 Months Ended
	Apr. 01, 2023	Aug. 31, 2023
Leases [Abstract]
Rental Payments		$ 6,650
Operating lease liability totaling	$ 225,887
Treasury Rate	3.81%

Operating Lease Right of Use _4

Operating Lease Right of Use Asset and Lease Liability - Schedule of lease payments (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
2024	$ 79,800
2025	79,800
2026	46,550
Thereafter	0
Total lease payments	206,150
Less: present value discount	(10,116)
Total lease liabilities	196,034	$ 0
Less: current portion	(73,608)	0
Non-current lease liabilities	$ 122,426	$ 0

Operating Lease Right of Use _5

Operating Lease Right of Use Asset and Lease Liability - Schedule of additional information pertaining to our leases (Details)	6 Months Ended
	Aug. 31, 2023 USD ($)
Leases [Abstract]
Operating cash flows from operating leases	$ 6,650
Weighted average remaining lease term – operating leases	2 years 7 months 6 days
Weighted average discount rate – operating leases	3.81%

Note Payable Related Party - Ad

Note Payable Related Party - Additional Information (Details) - USD ($)		6 Months Ended	12 Months Ended
	Oct. 12, 2022	Aug. 31, 2023	Feb. 28, 2023	Jul. 18, 2023
Related Party Transaction [Line Items]
Note Payable Related party		$ 291,500	$ 293,000
Notes Payable, Current, Related Party, Type [Extensible Enumeration]		Related Party [Member]	Related Party [Member]
Mr . James [Member]
Related Party Transaction [Line Items]
Loan received			$ 32,500
David Deming [Member]
Related Party Transaction [Line Items]
Note Payable Related party				$ 195,000
Notes Payable, Current, Related Party, Type [Extensible Enumeration]				Related Party [Member]
Loan received		$ 50,000	195,000
Number of shares authorized for issuance of Common Shares				5,270,271
Debt Instrument, Convertible, Conversion Price				$ 0.037
Mango Moi, LLC [Member]
Related Party Transaction [Line Items]
Note Payable Related party		$ 17,500
Notes Payable, Current, Related Party, Type [Extensible Enumeration]		Related Party [Member]
Loan received	$ 35,000	$ 35,000
Number of shares authorized for issuance of Common Shares	760,870
Debt Instrument, Convertible, Conversion Price	$ 0.023
Debt instrument convertible feature to retire the loan	$ 17,500
Debt Instrument, Face Amount	$ 35,000
Ian James [Member]
Related Party Transaction [Line Items]
Loan received		171,000	$ 48,000
Repayment of long term debt		$ 10,000

Deferred Compensation (Details)

Deferred Compensation (Details) - USD ($)		3 Months Ended	6 Months Ended
	Jul. 18, 2023	Aug. 31, 2023	Aug. 31, 2023	Feb. 28, 2023
Deferred Compensation [Line Items]
Deferred compensation		$ 248,976	$ 248,976	$ 379,759
Deferred compensation arrangement with individual fair value of shares issued		$ 331,103	$ 331,103
Ian James [Member]
Deferred Compensation [Line Items]
Deferred compensation arrangement with individual fair value of shares issued	$ 186,096
Deferred compensation arrangement with individual shares issued	5,029,622
Deferred share based compensation issue price per share	$ 0.037
Stephen Letourneau [Member]
Deferred Compensation [Line Items]
Deferred compensation arrangement with individual fair value of shares issued	$ 145,007
Deferred compensation arrangement with individual shares issued	3,919,109
Deferred share based compensation issue price per share	$ 0.037

Stock Purchase Warrant Liabil_2

Stock Purchase Warrant Liability (Details) - USD ($)	6 Months Ended
	Aug. 31, 2023	Feb. 28, 2023	Jun. 07, 2022	Apr. 18, 2022
Class of Warrant or Right [Line Items]
Stock purchase warrant liability description	On April 18, 2022, we entered into a Standby Equity Commitment Agreement with MacRab LLC, a Florida limited liability company providing us with an option to sell up to $5,000,000 worth of our Common Stock, par value $0.0001, to MacRab LLC, in increments, over the period ending 24 months after the date that the Company’s registration statement is deemed effective by the U.S. Securities and Exchange Commission, pursuant to the terms and conditions contained in the SECA. Additionally, we issued MacRab LLC a Common Stock purchase warrant for the purchase of 1,785,714 shares of our common stock as a commitment fee in connection with the execution of the Standby Equity Commitment Agreement. We also entered into a Registration Rights Agreement with the Investor requiring the Company to file a registration statement providing for the registration of the Common Stock issuable to MacRab LLC under the Standby Equity Commitment Agreement and their common stock purchase warrant, and the subsequent resale by MacRab LLC of such Common Stock.
Purchase agreement fees (in Dollars)			$ 22,320
Non-callable warrants	8%
Purchase common stock percentage	120%
Warrants exercisable date of issuance	5 years
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Macrab LLB [Member] | Standby Equity Commitement Agreement [Member]
Class of Warrant or Right [Line Items]
Common stock shares subscriptions				$ 5,000,000
Common stock par or stated value per share				$ 0.0001
Macrab LLB [Member] | Standby Equity Commitement Agreement [Member] | Common Stock Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants exercisable date of issuance				24 months
Class of warrant or right number of securities called by warrants or rights				1,785,714

Shareholder Equity (Details)

Shareholder Equity (Details) - USD ($)										1 Months Ended	3 Months Ended	6 Months Ended		12 Months Ended
	Jul. 18, 2023	Jun. 30, 2023	Mar. 31, 2023	Jul. 11, 2022	Jun. 18, 2022	May 26, 2022	Apr. 12, 2022	Jan. 01, 2022	Dec. 31, 2021	May 31, 2022	Aug. 31, 2023	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023
Shareholder Equity (Details) [Line Items]
Preferred stock, shares authorized											200,000,000	200,000,000		200,000,000
Preferred stock, par value (in Dollars per share)											$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, shares issued											700,000	700,000		700,000
Preferred stock shares outstanding											700,000	700,000		700,000
Common stock, shares authorized											500,000,000	500,000,000		500,000,000
Common stock, par value (in Dollars per share)											$ 0.0001	$ 0.0001		$ 0.0001
Common stock, shares issued											419,209,183	419,209,183		404,014,987
Common stock, shares outstanding											419,209,183	419,209,183		404,014,987
Restricted common stock (in Dollars)										$ 40,248
Commitment shares												4,960,000
Number of vested shares												14,000,000
Stock option, description												6,000,000 shares vest over the next year.
Stock option expire term												5 years
Stock options fair value the grant date (in Dollars per share)												$ 4,853,749
Stock price (in Dollars per share)								$ 11			$ 22	$ 22
Expected term								5 years				5 years
Interest rate								1.26%				1.01%
Total stock option expense (in Dollars)												$ 546,594	$ 917,062
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number											20,000,000	20,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price											$ 25	$ 25
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate								163%				172%
Total Unamortized Stock Option Expense												$ 68,020		$ 614,613
Deferred compensation arrangement with individual fair value of shares issued											$ 331,103	$ 331,103
Common Share Option Cancellation Agreement [Member] | Nicola Finley [Member]
Shareholder Equity (Details) [Line Items]
Common stock, par value (in Dollars per share)				$ 1
Share Based Compensation By Share Based Award Options To Purchase Shares Forfeited				4,000,000
Mango Moi, LLC [Member]
Shareholder Equity (Details) [Line Items]
Shares of restricted common stock						11,000,000
Closing share price (in Dollars)						$ 550,000
Director [Member] | Leslie [Member]
Shareholder Equity (Details) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares					444,563				703,891
Director [Member] | Five Directors [Member]
Shareholder Equity (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross							125,000
Stock Issued During Period, Value, Restricted Stock Award, Gross							$ 15,468
Director [Member] | Four Directors [Member]
Shareholder Equity (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross		100,000	100,000
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 1,000	$ 950
Chief Financial Officer [Member]
Shareholder Equity (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross		775,194
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 10,000
Restricted Common Stock [Member]
Shareholder Equity (Details) [Line Items]
Shares of restricted common stock										325,000
Ian James [Member]
Shareholder Equity (Details) [Line Items]
Deferred compensation arrangement with individual fair value of shares issued	$ 186,096
Deferred compensation arrangement with individual shares issued	5,029,622
Deferred share based compensation issue price per share	$ 0.037
Stephen Letourneau Member
Shareholder Equity (Details) [Line Items]
Deferred compensation arrangement with individual fair value of shares issued	$ 145,007
Deferred compensation arrangement with individual shares issued	3,919,109
Deferred share based compensation issue price per share	$ 0.037
David Deming [Member]
Shareholder Equity (Details) [Line Items]
Deferred compensation arrangement with individual fair value of shares issued	$ 195,000
Deferred compensation arrangement with individual shares issued	5,270,271
Debt instrument conversion price per share	$ 0.037

Business Combinations (Details)

Business Combinations (Details) - USD ($)	6 Months Ended
	Aug. 31, 2023	Feb. 28, 2023	Apr. 29, 2022
Business Acquisition [Line Items]
Purchase price of stock	$ 557,000
Goodwill	$ 583,484
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Shares of common stock	500,000,000	500,000,000
Fair market value (in Dollars)			$ 550,000
Common stock, shares issued	419,209,183	404,014,987
Mango Moi, LLC [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Common stock, par value (in Dollars per share)			$ 0.0001
Shares of common stock			11,000,000
Amanda Cayemitte [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Common stock, shares issued			5,720,000
Yapo M'be [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Common stock, shares issued			5,280,000

Business Combinations (Detail_2

Business Combinations (Details) - Schedule of fair value of such assets and liabilities	Apr. 29, 2022 USD ($)
Assets Acquired:
Cash	$ 913
Inventory	12,995
Total Assets Acquired	13,908
Liabilities assumed:
Clearbanc debit card	2,365
Notes payable - paypal capital	2,454
Notes payable shopify capital	537
Note payable gushy	35,000
Sales tax payable	36
Total liabilities assumed	40,392
Total identifiable net assets	(26,484)
Purchase price	557,000
Goodwill - excess of purchase price over fair value of net assets acquired on acquisition date	$ 583,484

Commitments and Contingencies (

Commitments and Contingencies (Details)	6 Months Ended
	Aug. 31, 2023 USD ($)
Ian James Employment Agreement [Member]
Additional fees	$ 199,196
Base salary per annum	16,599.67
Additional payment	68,328
Stephen Letourneau Employment Agreement [Member]
Additional fees	152,787
Base salary per annum	12,732.25
Additional payment	41,140
Jacob Ellman Employment Agreement [Member]
Additional fees	128,656
Base salary per annum	10,721.33
Additional payment	$ 70,632

Subsequent Events (Details)

Subsequent Events (Details)	Sep. 26, 2023 USD ($) shares	Sep. 18, 2023 USD ($) Votes $ / shares	Aug. 31, 2023 $ / shares	Feb. 28, 2023 $ / shares
Subsequent Events (Details) [Line Items]
Preferred stock par or stated value per share | $ / shares			$ 0.0001	$ 0.0001
Common stock par or stated value per share | $ / shares			$ 0.0001	$ 0.0001
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Directors term	2 years
Cash compensation per quarter	$ 1,000
Number of common shares reserved for future issuance related to deferred compensation arrangements | shares	200,000
Tranche of deferred compensation share distributions | shares	25,000
Subsequent Event [Member] | Membership Interest Purchase Agreement [Member] | Ideation Lab LLC [Member]
Subsequent Events (Details) [Line Items]
Amount payable for the purchase of membership interest		$ 3,000,000
Preferred stock par or stated value per share | $ / shares		$ 0.0001
Common stock par or stated value per share | $ / shares		$ 0.0001
Preferred stock number of votes per share | Votes		1,000
Subsequent Event [Member] | Securities Purchase Agreement One [Member] | Promissory Note Amendment Agreement [Member]
Subsequent Events (Details) [Line Items]
Debt instrument face value		$ 310,000
Long term debt increase in the principal amount		$ 40,891
Long term debt fixed interest rate percentage		18%
Long term debt maturity date		Sep. 13, 2024
Subsequent Event [Member] | Securities Purchase Agreement Two [Member] | Promissory Note Amendment Agreement [Member]
Subsequent Events (Details) [Line Items]
Debt instrument face value		$ 310,000
Long term debt increase in the principal amount		$ 40,023
Long term debt fixed interest rate percentage		18%
Long term debt maturity date		Sep. 13, 2024